AIG
GTBP icon

American International Group’s GT Biopharma GTBP Stock Holding History

American International Group’s Portfolio GTBP Stock Details GTBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-294
Closed -$25K – 3165
2022
Q1 		$25K Sell
294
-20
-6% -$1.76K ﹤0.01% 2997
2021
Q4 		$29K Sell
314
-10
-3% -$1.5K ﹤0.01% 3060
2021
Q3 		$65K Sell
324
-121
-27% -$36.4K ﹤0.01% 2943
2021
Q2 		$207 Buy
+445
New +$185K ﹤0.01% 2482

Other funds holding GTBP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
AWS
Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

American International Group's GTBP Position: Q2 2022 in Review

American International Group sold out of GT Biopharma (GTBP) in Q2 2022, closing a stake of 294 shares — an estimated $25K sold.

American International Group first reported a position in GTBP in Q2 2021 and held it in 4 quarters. The position peaked at $65K in Q3 2021. 47 funds tracked by Wall St. Rank hold GTBP as of Q2 2022.

  • American International Group reported no remaining GT Biopharma position as of Q2 2022 after selling out during the quarter.
  • American International Group sold 294 GT Biopharma shares in Q2 2022, an estimated $25K.
  • American International Group first reported a position in GT Biopharma in Q2 2021 and held it in 4 quarters.
  • American International Group's GT Biopharma position peaked at $65K in Q3 2021.
  • 47 funds tracked by Wall St. Rank held GT Biopharma as of Q2 2022.

Based on American International Group's 13F filing for Q2 2022, filed 12 Aug 2022.